In order to discover such compounds, we assayed the Selleck bioactive library of 2658 compounds for enhancement of G418-induced PTC readthrough in HDQ-P1 cancer cells carrying homozygous TP53 R213X nonsense mutations. This evidence concerns the gene TP53 and cancer.